Latvia - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes

Since 2014, Latvia Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes rose 8.8% year on year. In 2019, the country was number 27 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes with €94.33 Per Capita. Latvia is overtaken by Estonia, which was ranked number 26 at €118.49 Per Capita and is followed by Lithuania with €91.65 Per Capita. Switzerland topped the ranking with €666.37 Per Capita in 2019, an increase of 3.2% compared to 2018. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia recorded the best 5 years average growth at +8.8% per year, while Romania was the worst growing country at -1.7% per year.

Loading...

Date Euros Per Capita
2019 94.33
2018 95.20
2017 83.07
2016 79.04
2015 66.52
Download all data from 2013 to 2019

How does Latvia rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?

# 33 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
666.37 2019 +3.1 % +5.3 % View data
2 #2
Germany
553.39 2019 +2.3 % +3.0 % View data
26 #26
Estonia
118.49 2019 +3.3 % +5.4 % View data
27 #27
Latvia
94.33 2019 -0.9 % +8.8 % View data
28 #28
Lithuania
91.65 2019 +0.8 % +5.4 % View data
Compare all 33 countries

Go Top